Research Frontiers Reports Third Quarter 2020 Financial Results
Research Frontiers Inc. (Nasdaq: REFR) reported its third quarter results for the period ending September 30, 2020. The company generated fee income of $692,714 from licensing activities, down from $1,182,560 in the same period last year. This decline was driven by lower fees in automotive and aircraft markets, partially offset by gains in architecture and display sectors. Total expenses decreased by approximately 23% to $716,661. As of September 30, REFR had approximately $5.4 million in cash and sufficient working capital for the next 27-29 months.
- Expenses decreased by approximately 23% compared to the previous year.
- The company expects sufficient working capital for at least the next 27-29 months.
- Fee income from licensing activities decreased by approximately 41.5% year-over-year.
- Lower fees in the automotive and aircraft markets.
Management to Host Conference Call at 4:30 p.m.
WOODBURY, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its third quarter ended September 30, 2020. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.
- Who: Joseph M. Harary, President & CEO, Seth Van Voorhees, CFO
- Date/Time: November 5, 2020, 4:30 PM ET
- Dial-in Information: 1-888-334-5785
- Replay: Available on Friday, November 6, 2020 for 90 days at www.SmartGlass-IR.com
Key Third Quarter 2020 Comments:
1. The Company’s fee income from licensing activities for the nine months ended September 30, 2020 was
2. Total expenses decreased by
3. As of September 30, 2020, the Company had cash and cash equivalents of approximately
For more details, please see the Company’s Quarterly Report on Form 10-Q which was filed today with the SEC, the contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to over 40 companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT:
Seth L. Van Voorhees
Chief Financial Officer
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATED
Consolidated Balance Sheets
| September 30, 2020 (Unaudited) | December 31, 2019 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 5,440,208 | $ | 6,591,960 | ||||
| Royalties receivable, net of reserves of September 30, 2020 and | 554,609 | 656,062 | ||||||
| Prepaid expenses and other current assets | 107,041 | 58,835 | ||||||
| Total current assets | 6,101,858 | 7,306,857 | ||||||
| Fixed assets, net | 72,715 | 141,720 | ||||||
| Operating lease ROU assets | 653,097 | 773,989 | ||||||
| Deposits and other assets | 33,567 | 33,567 | ||||||
| Total assets | $ | 6,861,237 | $ | 8,256,133 | ||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of operating lease liabilities | $ | 162,615 | $ | 163,236 | ||||
| Accounts payable | 47,324 | 169,750 | ||||||
| Accrued expenses and other | 58,213 | 46,709 | ||||||
| Deferred revenue | 21,511 | 7,734 | ||||||
| Total current liabilities | 289,663 | 387,429 | ||||||
| Operating lease liabilities, net of current portion | 689,057 | 812,596 | ||||||
| Total liabilities | 978,720 | 1,200,025 | ||||||
| Shareholders’ equity: | ||||||||
| Common stock, par value | 3,158 | 3,125 | ||||||
| Additional paid-in capital | 122,837,069 | 122,552,895 | ||||||
| Accumulated deficit | (116,957,710 | ) | (115,499,912 | ) | ||||
| Total shareholders’ equity | 5,882,517 | 7,056,108 | ||||||
| Total liabilities and shareholders’ equity | $ | 6,861,237 | $ | 8,256,133 | ||||
RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Operations
Unaudited
| Nine Months Ended September 30, | Three Months Ended September 30, | |||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Fee income | $ | 697,914 | $ | 1,182,560 | $ | 165,628 | $ | 462,869 | ||||||||
| Operating expenses | 1,924,828 | 2,356,875 | 472,424 | 666,356 | ||||||||||||
| Research and development | 466,698 | 751,312 | 136,649 | 207,368 | ||||||||||||
| Total expenses | 2,391,526 | 3,108,187 | 609,073 | 873,724 | ||||||||||||
| Operating loss | (1,693,612 | ) | (1,925,627 | ) | (443,445 | ) | (410,855 | ) | ||||||||
| Warrant market adjustment | - | (652,025 | ) | - | - | |||||||||||
| Other income -PPP loan forgiveness | 202,052 | - | 7,912 | - | ||||||||||||
| Net investment income | 33,762 | 25,565 | 1,310 | 13,143 | ||||||||||||
| Net loss | $ | (1,457,798 | ) | $ | (2,552,087 | ) | $ | (434,223 | ) | $ | (397,712 | ) | ||||
| Basic and diluted net loss per common share | $ | (0.05 | ) | $ | (0.09 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
| Basic and diluted weighted average number of common shares outstanding | 31,458,238 | 29,636,013 | 31,575,786 | 31,065,730 | ||||||||||||
RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Cash Flows
Unaudited
| Nine Months Ended September 30, | ||||||||
| 2020 | 2019 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (1,457,798 | ) | $ | (2,552,087 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 64,193 | 146,496 | ||||||
| Stock-based compensation | - | 356,228 | ||||||
| Bad debt expense | 53,217 | 22,667 | ||||||
| Warrant market adjustment | - | 652,025 | ||||||
| Other income -PPP loan forgiveness | (202,052 | ) | - | |||||
| Change in assets and liabilities: | ||||||||
| Royalty receivables | 48,234 | (108,750 | ) | |||||
| Prepaid expenses and other current assets | (48,206 | ) | (53,155 | ) | ||||
| Accounts payable and accrued expenses | (110,921 | ) | (142,477 | ) | ||||
| Deferred revenue | 13,777 | 21,095 | ||||||
| Net cash used in operating activities | (1,639,556 | ) | (1,657,958 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of fixed assets | (2,168 | ) | (65,081 | ) | ||||
| Proceeds from the sale of fixed assets | 3,713 | - | ||||||
| Net cash provided by (used in) investing activities | 1,545 | (65,081 | ) | |||||
| Cash flows from financing activities: | ||||||||
| Net proceeds from issuances of common stock and warrants and exercise of options and warrants | 284,207 | 5,770,545 | ||||||
| Proceeds from PPP Program Funding | 202,052 | - | ||||||
| Net cash provided by financing activities | 486,259 | 5,770,545 | ||||||
| Net (decrease)/increase in cash and cash equivalents | (1,151,752 | ) | 4,047,506 | |||||
| Cash and cash equivalents at beginning of period | 6,591,960 | 2,969,416 | ||||||
| Cash and cash equivalents at end of period | $ | 5,440,208 | $ | 7,016,922 | ||||
FAQ
What were Research Frontiers' third quarter earnings for 2020?
How much cash does Research Frontiers have as of September 30, 2020?
What are the future financial expectations for Research Frontiers?
When will Research Frontiers hold its Q3 2020 conference call?
